Autoimmune meningoencephalitis associated with anti‐glutamic acid decarboxylase antibody following COVID‐19 infection: A case report

Mehri Salari; Bahareh Zaker Harofteh; Masoud Etemadifar

doi:10.1002/ccr3.6597

Clinical Case Reports (Dec 2022)

Autoimmune meningoencephalitis associated with anti‐glutamic acid decarboxylase antibody following COVID‐19 infection: A case report

Mehri Salari,
Bahareh Zaker Harofteh,
Masoud Etemadifar

Affiliations

Mehri Salari: Department of Neurological disease Shahid Beheshti University of Medical Sciences Tehran Iran
Bahareh Zaker Harofteh: Department of Neurological disease Shahid Beheshti University of Medical Sciences Tehran Iran
Masoud Etemadifar: Department of Neurosurgery, Al Zahra University Hospital Isfahan University of Medical Sciences Isfahan Iran

DOI: https://doi.org/10.1002/ccr3.6597
Journal volume & issue: Vol. 10, no. 12
pp. n/a – n/a

Abstract

Read online

Abstract Anti‐glutamic acid decarboxylase (Anti‐GAD) are associated with various neurologic condition; but no meningitis has been reported with it, so far. Evidence demonstrates the associated of autoimmune meningoencephalitis with COVID‐19 infection. Here, we report a 44‐year‐old female with progressive loss of consciousness with anti‐GAD65 meningoencephalitis 1 month after COVID‐19 infection.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords